Lucid Diagnostics Inc. Common Stock (NASDAQ: LUCD) last traded at $0.964, up 0.41% on the session. The quote above updates while this page is open; the figures below are drawn from Lucid Diagnostics Inc. Common Stock’s own filings and are restated only when a new one is published.
Lucid Diagnostics Inc. Common Stock trades on NASDAQ under the ticker LUCD. Its market capitalisation is $195.99 million.
Valuation measures for Lucid Diagnostics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $195.99M |
|---|---|
| Enterprise value | $176.68M |
| Price / sales | 35.99 |
| Price / book | 17.94 |
| Beta | 1.26 |
Trailing-twelve-month figures tagged in Lucid Diagnostics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $5.45M |
|---|---|
| Net income (TTM) | -$52.26M |
| EPS (TTM) | -$0.340 |
| Operating margin | -930.84% |
| Return on equity | -478.26% |
| Cash | $47.33M |
Range and volume for LUCD over the past 52 weeks.
| 52-week high | $1.63 |
|---|---|
| 52-week low | $0.861 |
| Volume | 410.0K |
| Average volume | 1.42M |
| Previous close | $0.960 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.